4.1 Article

On selecting the critical boundary functions in group-sequential trials with two time-to-event outcomes

Related references

Note: Only part of the references are listed.
Article Mathematics, Interdisciplinary Applications

Group-sequential logrank methods for trial designs using bivariate non-competing event-time outcomes

Tomoyuki Sugimoto et al.

LIFETIME DATA ANALYSIS (2020)

Article Mathematical & Computational Biology

Hierarchical Testing of a Primary and a Secondary Endpoint in a Group Sequential Design With Different Information Times

Jiangtao Gou et al.

STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2019)

Article Mathematical & Computational Biology

Interim evaluation of efficacy or futility in group-sequential trials with multiple co-primary endpoints

Koko Asakura et al.

BIOMETRICAL JOURNAL (2017)

Article Pharmacology & Pharmacy

Statistical challenges in a regulatory review of cardiovascular and CNS clinical trials

H. M. James Hung et al.

JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2016)

Article Mathematical & Computational Biology

Group-Sequential Strategies in Clinical Trials with Multiple Co-Primary Outcomes

Toshimitsu Hamasaki et al.

STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2015)

Article Mathematical & Computational Biology

Allocating recycled significance levels in group sequential procedures for multiple endpoints

Dong Xi et al.

BIOMETRICAL JOURNAL (2015)

Article Mathematical & Computational Biology

Sample size determination in group-sequential clinical trials with two co-primary endpoints

Koko Asakura et al.

STATISTICS IN MEDICINE (2014)

Article Mathematical & Computational Biology

A group sequential Holm procedure with multiple primary endpoints

Yining Ye et al.

STATISTICS IN MEDICINE (2013)

Article Mathematical & Computational Biology

Multiple Testing in Group Sequential Trials Using Graphical Approaches

Willi Maurer et al.

STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2013)

Article Mathematical & Computational Biology

Hierarchical testing of multiple endpoints in group-sequential trials

Ekkehard Glimm et al.

STATISTICS IN MEDICINE (2010)

Article Pharmacology & Pharmacy

Statistical considerations for testing multiple endpoints in group sequential or adaptive clinical trials

H. M. James Hung et al.

JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2007)

Article Medicine, Research & Experimental

Computations for group sequential boundaries using the Lan-DeMets spending function method

DM Reboussin et al.

CONTROLLED CLINICAL TRIALS (2000)